Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1060 | 1045 | 1100 | 1247 | 1353 | 1734 |
Fund Return | 5.98% | 4.46% | 10.05% | 7.64% | 6.23% | 5.66% |
Place in category | 1374 | 1344 | 1148 | 566 | 936 | 534 |
% in Category | 65 | 64 | 58 | 32 | 62 | 57 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Fundc | 15.7B | 15.39 | 2.71 | 10.71 | ||
Capital Group New Perspective Funzc | 15.7B | 15.17 | 2.46 | 10.51 | ||
Capital Group New Perspective Fuzdc | 15.7B | 15.16 | 2.45 | 10.50 | ||
Capital Group New Perspective Fubc | 15.7B | 14.56 | 1.68 | 9.63 | ||
Capital Group Global Allocation Fzc | 1.51B | 10.48 | 4.11 | 7.25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wellington Strategic European EquiC | 3.21B | 2.61 | 5.50 | 5.93 | ||
Wellington Strategic European EquiN | 3.21B | 2.68 | 6.30 | 6.72 | ||
Capital Group European Growth and c | 155.93M | 10.90 | 7.39 | 6.86 | ||
EU Growth and Income Fund LUXB | 155.93M | 10.06 | 6.17 | 5.75 | ||
EU Growth and Income Fund LUXC | 155.93M | 11.15 | 7.78 | 7.38 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Imperial Brands | GB0004544929 | 4.11 | 2,182.00 | +0.23% | |
Novo Nordisk B | DK0062498333 | 3.58 | 796.5 | -4.59% | |
ING Groep | NL0011821202 | 3.53 | 16.53 | -0.48% | |
Next | GB0032089863 | 3.45 | 9,742.0 | -3.54% | |
E.ON SE | DE000ENAG999 | 3.35 | 13.470 | +0.60% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | - | - | - |
Technical Indicators | - | - | - |
Summary | Neutral | Neutral | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review